Gregory Alan Korbel

Insider Reports History

Entity
Individual
Location
535 Boylston Street, Boston, MA
Signature
/s/ Scott M. Coiante, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory Alan Korbel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aprea Therapeutics, Inc. SVP, Chief Operating Officer Common Stock 45.8K $168K $3.68 Jul 28, 2022 Direct
Aprea Therapeutics, Inc. SVP, Chief Operating Officer Stock Option (right to Buy) 35.7K Jul 28, 2022 Direct

Insider Reports Filed by Gregory Alan Korbel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APRE Aprea Therapeutics, Inc. Jul 28, 2022 2 $0 4 Aug 1, 2022 SVP, Chief Operating Officer
APRE Aprea Therapeutics, Inc. Jun 3, 2022 1 -$6.75K 4 Jun 7, 2022 SVP, Chief Operating Officer, Director
APRE Aprea Therapeutics, Inc. Mar 10, 2022 3 -$3.62K 4 Mar 14, 2022 SVP, Chief Business Officer, Director
APRE Aprea Therapeutics, Inc. Feb 25, 2022 1 -$2.31K 4 Mar 1, 2022 SVP, Chief Business Officer
APRE Aprea Therapeutics, Inc. Dec 1, 2021 3 -$83.6K 4 Dec 3, 2021 SVP, Chief Business Officer
APRE Aprea Therapeutics, Inc. Nov 1, 2021 4 -$112K 4 Nov 3, 2021 SVP, Chief Business Officer
APRE Aprea Therapeutics, Inc. Oct 1, 2021 3 -$109K 4 Oct 5, 2021 SVP, Chief Business Officer
APRE Aprea Therapeutics, Inc. Sep 20, 2021 4 -$139K 4 Sep 22, 2021 SVP, Chief Business Officer
APRE Aprea Therapeutics, Inc. Sep 10, 2021 1 -$7.91K 4 Sep 14, 2021 Chief Business Officer
APRE Aprea Therapeutics, Inc. Aug 25, 2021 1 -$4.57K 4 Aug 27, 2021 Chief Business Officer